109 related articles for article (PubMed ID: 12966610)
1. Antimonocyte antibodies in Takayasu's arteritis: prevalence of and relation to disease activity.
Tripathy NK; Sinha N; Nityanand S
J Rheumatol; 2003 Sep; 30(9):2023-6. PubMed ID: 12966610
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 12 in Takayasu's arteritis: plasma concentrations and relationship with disease activity.
Verma DK; Tripathy NK; Verma NS; Tiwari S
J Rheumatol; 2005 Dec; 32(12):2361-3. PubMed ID: 16331764
[TBL] [Abstract][Full Text] [Related]
3. Soluble endothelial cell adhesion molecules and their relationship to disease activity in Takayasu's arteritis.
Tripathy NK; Chandran V; Garg NK; Sinha N; Nityanand S
J Rheumatol; 2008 Sep; 35(9):1842-5. PubMed ID: 18597403
[TBL] [Abstract][Full Text] [Related]
4. Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis.
Park MC; Lee SW; Park YB; Lee SK
Rheumatology (Oxford); 2006 May; 45(5):545-8. PubMed ID: 16352633
[TBL] [Abstract][Full Text] [Related]
5. Raised agalactosyl IgG and antimycobacterial humoral immunity in Takayasu's arteritis.
Hernández-Pando R; Reyes P; Espitia C; Wang Y; Rook G; Mancilla R
J Rheumatol; 1994 Oct; 21(10):1870-6. PubMed ID: 7837153
[TBL] [Abstract][Full Text] [Related]
6. Antigenic targets and pathogenicity of anti-aortic endothelial cell antibodies in Takayasu arteritis.
Chauhan SK; Tripathy NK; Nityanand S
Arthritis Rheum; 2006 Jul; 54(7):2326-33. PubMed ID: 16802373
[TBL] [Abstract][Full Text] [Related]
7. Role of C-C chemokines in Takayasu's arteritis disease.
Dhawan V; Mahajan N; Jain S
Int J Cardiol; 2006 Sep; 112(1):105-11. PubMed ID: 16647147
[TBL] [Abstract][Full Text] [Related]
8. Anti-endothelial cell antibodies and antiphospholipid antibodies in Takayasu's arteritis: correlations of their titers and isotype distributions with disease activity.
Park MC; Park YB; Jung SY; Lee KH; Lee SK
Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S10-6. PubMed ID: 16859589
[TBL] [Abstract][Full Text] [Related]
9. High TNF-alpha and low IL-2 producing T cells characterize active disease in Takayasu's arteritis.
Tripathy NK; Gupta PC; Nityanand S
Clin Immunol; 2006; 118(2-3):154-8. PubMed ID: 16337833
[TBL] [Abstract][Full Text] [Related]
10. Enzyme-linked immunosorbent assay and immunoblot study in Takayasu's arteritis patients.
Dhingra R; Chopra P; Talwar KK; Kumar R
Indian Heart J; 1998; 50(4):428-32. PubMed ID: 9835204
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary study on differential expression of plasma proteins of patients with Takayasu's arteritis in different stage].
Luo XY; Wu QH; Chen Z; Ma J; Han YM; Tang XB; Wu ZM; Kou L; Liu H; Li Q; Jia YF; Zhang Z; He N
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(3):157-60. PubMed ID: 20356548
[TBL] [Abstract][Full Text] [Related]
12. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
13. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis.
Valsakumar AK; Valappil UC; Jorapur V; Garg N; Nityanand S; Sinha N
J Rheumatol; 2003 Aug; 30(8):1793-8. PubMed ID: 12913937
[TBL] [Abstract][Full Text] [Related]
14. T-cell receptor repertoire of circulating gamma delta T-cells in Takayasu's arteritis.
Chauhan SK; Tripathy NK; Sinha N; Nityanand S
Clin Immunol; 2006; 118(2-3):243-9. PubMed ID: 16307908
[TBL] [Abstract][Full Text] [Related]
15. Circulating B lymphocytes producing autoantibodies to endothelial cells play a role in the pathogenesis of Takayasu arteritis.
Wang H; Ma J; Wu Q; Luo X; Chen Z; Kou L
J Vasc Surg; 2011 Jan; 53(1):174-80. PubMed ID: 20832232
[TBL] [Abstract][Full Text] [Related]
16. Anti-annexin V antibodies in Takayasu's arteritis: prevalence and relationship with disease activity.
Tripathy NK; Sinha N; Nityanand S
Clin Exp Immunol; 2003 Nov; 134(2):360-4. PubMed ID: 14616799
[TBL] [Abstract][Full Text] [Related]
17. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
[TBL] [Abstract][Full Text] [Related]
18. Assessment of disease activity and progression in Takayasu's arteritis with Disease Extent Index-Takayasu.
Aydin SZ; Yilmaz N; Akar S; Aksu K; Kamali S; Yucel E; Karadag O; Bicakcigil M; Ozer H; Kiraz S; Onen F; Inanc M; Keser G; Akkoc N; Direskeneli H
Rheumatology (Oxford); 2010 Oct; 49(10):1889-93. PubMed ID: 20542893
[TBL] [Abstract][Full Text] [Related]
19. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
20. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
Guo H; Leung JC; Chan LY; Chan TM; Lai KN
Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
